OTUB1

Ubiquitin thioesterase OTUB1 · Q96FW1 · OTUB1 on Sugi Atlas →

259 patent compounds predicted against OTUB1, 148 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL19220487 SCHEMBL19220487 0.67 4/20
SCHEMBL19220488 SCHEMBL19220488 0.66 4/20
SCHEMBL21498209 SCHEMBL21498209 0.64 4/20
SCHEMBL7808410 SCHEMBL7808410 0.62 4/20
SCHEMBL7808446 SCHEMBL7808446 0.61 4/20
SCHEMBL7808123 SCHEMBL7808123 0.57 4/20
SCHEMBL7808221 SCHEMBL7808221 0.57 4/20
SCHEMBL7815859 SCHEMBL7815859 0.62 3/20
SCHEMBL31276578 SCHEMBL31276578 0.62 3/20
SCHEMBL19198299 SCHEMBL19198299 0.51 3/20
SCHEMBL2401601 SCHEMBL2401601 0.33 3/20
SCHEMBL19220486 SCHEMBL19220486 0.74 2/20
SCHEMBL7808226 SCHEMBL7808226 0.73 2/20
SCHEMBL29629183 SCHEMBL29629183 0.73 2/20
SCHEMBL29629184 SCHEMBL29629184 0.73 2/20
SCHEMBL7968066 SCHEMBL7968066 0.62 2/20
SCHEMBL19225117 SCHEMBL19225117 0.62 2/20
SCHEMBL7812967 SCHEMBL7812967 0.61 2/20
SCHEMBL7808315 SCHEMBL7808315 0.58 2/20
SCHEMBL7811858 SCHEMBL7811858 0.57 2/20

Clinical trials — most relevant to OTUB1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Relapsed and/or Refractory Non-Hodgkin Lymphoma Study PHASE2WITHDRAWN
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma PHASE2WITHDRAWN
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma PHASE2SUSPENDED
Studying TAK-243 in Patients With Advanced Cancer PHASE1RECRUITING
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease EARLY_PHASE1RECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 nanRECRUITING
Muscle Wasting in Hemodialysis Patient nanCOMPLETED
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Transcriptional and Epigenetic Program of PCOS Women nanACTIVE_NOT_RECRUITING
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome nanRECRUITING
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Biomarker Panel in Ovarian Torsion nanUNKNOWN
RNA Cloning and Visualization in Human Atherosclerosis nanCOMPLETED
Early Detection of Breast Cancer in Women With Suspicious Mammograms nanACTIVE_NOT_RECRUITING
Safety and Tolerability of a Nutritional Formula Designed to Aid in Maintenance of Muscle During Periods of Caloric Restriction in Adults nanNOT_YET_RECRUITING
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders nanCOMPLETED
Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach nanRECRUITING
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma nanCOMPLETED
Establishment of a Prospective Clinical-biological Database nanRECRUITING
Acute Pancreatitis Targets (APT) Study nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a OTUB1 binder may also engage these)

ProteinNameSimilarity
Q7TQI3 1.000 Q7TQI3 →
B2RYG6 1.000 B2RYG6 →
Q96DC9 0.990 Q96DC9 →
Q9VL00 0.990 Q9VL00 →
Q9CQX0 0.986 Q9CQX0 →
Q9XVR6 0.973 Q9XVR6 →
A8XDJ2 0.971 A8XDJ2 →
Q29FC9 0.970 Q29FC9 →
Q9LPT6 0.968 Q9LPT6 →
Q9LYC7 0.967 Q9LYC7 →
Q9VRJ9 0.965 Q9VRJ9 →
Q5ZJM3 0.964 Q5ZJM3 →
USP7 Ubiquitin carboxyl-terminal hydrolase 7 0.963 landscape →
Q4VSI4 0.963 Q4VSI4 →
Q7L8S5 0.963 Q7L8S5 →
Q6U7I1 0.963 Q6U7I1 →
Q7Q068 0.962 Q7Q068 →
Q9FFF2 0.962 Q9FFF2 →
Q567B1 0.961 Q567B1 →
Q17D30 0.961 Q17D30 →
Q6NX27 0.961 Q6NX27 →
Q803R5 0.961 Q803R5 →
Q0IH43 0.960 Q0IH43 →
P31669 0.960 P31669 →
Q6NTW6 0.960 Q6NTW6 →
SMS Spermine synthase 0.960 landscape →
Q6DDS9 0.960 Q6DDS9 →
Q6IE21 0.960 Q6IE21 →
Q9C5W6 0.960 Q9C5W6 →
P97355 0.960 P97355 →